Correlation Between Spero Therapeutics and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Spero Therapeutics and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Milestone Pharmaceuticals.
Diversification Opportunities for Spero Therapeutics and Milestone Pharmaceuticals
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Spero and Milestone is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between Spero Therapeutics and Milestone Pharmaceuticals
Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the Milestone Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Spero Therapeutics is 1.02 times less risky than Milestone Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Milestone Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 151.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 36.00 from holding Milestone Pharmaceuticals or generate 23.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spero Therapeutics vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| Spero Therapeutics |
| Milestone Pharmaceuticals |
Spero Therapeutics and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and Milestone Pharmaceuticals
The main advantage of trading using opposite Spero Therapeutics and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |